Majid Asghari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Majid Asghari has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Abolfazl Mohammadbeigi
Department of Epidemiology and Biostatistics, School of Health, Qom University of Medical Sciences, Qom, Iran
1 shared publication- Abolfazl Mohammadbeigi
School of Health, Qom University of Medical Sciences, Qom, Iran
1 shared publication Ahmad Hormati
Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Science, Qom, Iran
1 shared publication- Ahmad Hormati
Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Akram Asghari
Department of Internal Medicine, School of Medicine, Spiritual Health Research Center, Qom University of Medical Sciences, Qom, Iran
1 shared publication- Bagher Minaei Zangi
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- 1 December 2023
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 18 (2) , 1-7
Comparison of the Effects of Govarcin Herbal Capsule and Metoclopramide for Alleviating Gastrointestinal Symptoms in Patients with Functional Dyspepsia: A Randomized Double-blind Clinical Trial
Background: Functional dyspepsia (FD) is felt as a discomfort or pain on the center line or upper abdomen. In this study, we investigated the effect of Govarcin herbal capsule on FD so that if it is effective, it can be used in the treatment of patients with this disease. Methods: Totally, 106 patients enrolled in a double-blind, clinical trial study. The participants had FD and were divided into two groups receiving Govarcin and Metoclopramide by block randomization. The patients were treated for four weeks, taking one Govarcin capsule or Metoclopramide tablet after each meal. The rate of improvement in patients was assessed by mitigation of clinical symptoms, including epigastric pain, fullness, discomfort, nausea, vomiting and heartburn. Also, before and after intervention, we used Nepin questionnaire and ROME III. SPSS statistics 25 software was used for data analyzing. Results: Clinical symptom score changes between Govarcin and Metoclopramide patients’ groups showed that there was no significant difference in any of the clinical symptom scores (except for heartburn, p-vale=0.012) between the study groups. Nepean score in Govarcin group before and after treatment was 19.3±4.8 and 8.9±2.8, respectively (p-value<0.001). For Metoclopramide group, these values were 19.8±3.5 and 9.4±2.1 respectively (p-value<0.001). No significant difference was found in terms of Nepean score between the Govarcin and Metoclopramide groups (p-value=0.995). Conclusion: Govarcin herbal capsule can be used to remedy symptoms in patients with FD. It seems that Guarcin is as effective as metoclopramide in fighting symptoms of FD as no significant difference in efficacy has been demonstrated between them.
- 1 December 2023
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 18 (2) , 1-7
Comparison of the Effects of Govarcin Herbal Capsule and Metoclopramide for Alleviating Gastrointestinal Symptoms in Patients with Functional Dyspepsia: A Randomized Double-blind Clinical Trial
Background: Functional dyspepsia (FD) is felt as a discomfort or pain on the center line or upper abdomen. In this study, we investigated the effect of Govarcin herbal capsule on FD so that if it is effective, it can be used in the treatment of patients with this disease. Methods: Totally, 106 patients enrolled in a double-blind, clinical trial study. The participants had FD and were divided into two groups receiving Govarcin and Metoclopramide by block randomization. The patients were treated for four weeks, taking one Govarcin capsule or Metoclopramide tablet after each meal. The rate of improvement in patients was assessed by mitigation of clinical symptoms, including epigastric pain, fullness, discomfort, nausea, vomiting and heartburn. Also, before and after intervention, we used Nepin questionnaire and ROME III. SPSS statistics 25 software was used for data analyzing. Results: Clinical symptom score changes between Govarcin and Metoclopramide patients’ groups showed that there was no significant difference in any of the clinical symptom scores (except for heartburn, p-vale=0.012) between the study groups. Nepean score in Govarcin group before and after treatment was 19.3±4.8 and 8.9±2.8, respectively (p-value<0.001). For Metoclopramide group, these values were 19.8±3.5 and 9.4±2.1 respectively (p-value<0.001). No significant difference was found in terms of Nepean score between the Govarcin and Metoclopramide groups (p-value=0.995). Conclusion: Govarcin herbal capsule can be used to remedy symptoms in patients with FD. It seems that Guarcin is as effective as metoclopramide in fighting symptoms of FD as no significant difference in efficacy has been demonstrated between them.
- Open Access
- 1 April 2022
- Published by Medknow in Medical Gas Research
- Vol. 12 (2) , 44-50
Effects of Iranian Polyherbal Syrup (Zufa syrup) on oxygen saturation and clinical symptoms in suspected patients with COVID-19
Coronavirus disease 2019 (COVID-19) pandemic has caused an urgent need for investigating potential treatments. Traditional medicine offers many potential remedies that have been historically used and have the advantage of bypassing the cultural obstacles in the practice of medicine. We aimed to investigate the efficacy of Zufa syrup in the treatment of suspected patients with mild to moderate symptoms of COVID-19. This triple-blind randomized controlled trial recruited patients with evidence of COVID-19 on chest computed tomography without an indication of hospital admission from March 2020 until April 2020. Participants were assessed by a physician and completed a pre-specified form to assess the duration and severity of symptoms. Patients were randomized to receive Zufa syrup (a combination of herbal medicines: Nepetabracteata, Ziziphus jujube, Glycyrrhizaglabra, Ficuscarica, Cordia myxa, Papaver somniferum, Fennel, Adiantumcapillusveneris, Viola, Viper‘s-buglosses, Lavender, Iris, and sugar) or identical-looking placebo syrup at a dose of 7.5 mL (one tablespoon) every 4 hours for 10 days. After applying the eligibility criteria, 116 patients (49.1% male) were randomized to trial arms with a mean age of 44.3. During the follow-up, Cough, dyspnea, headache, myalgia, anorexia, anxiety, and insomnia improved gradually in both groups, and showed no difference between Zufa syrup and placebo. Oxygen saturation and pulse rate had stable trends throughout the follow-up and were similar between study arms. No patient required hospital admission or supplemental oxygen therapy during the study period. To conclude, in patients with mild to moderate symptoms of COVID-19, Zufa syrup did not show any difference in symptomatology over a 10 days’ period when compared with placebo. Due to potential effects of medicinal plants in the treatment of respiratory infections, further studies are warranted to clarify their role in COVID-19. The study was approved by the Ethics Committee of the Qom University of Medical Science (Ethics committee reference number IR.MUQ.REC.1398.165) on March 10, 2020 and was registered in Iranian Clinical Trial Center (approval ID: IRCT20200404046934N1) on April 13, 2020.
- 1 April 2022
- Published by Medknow in Medical Gas Research
- Vol. 12 (2) , 44-50
Open AccessEffects of Iranian Polyherbal Syrup (Zufa syrup) on oxygen saturation and clinical symptoms in suspected patients with COVID-19
Coronavirus disease 2019 (COVID-19) pandemic has caused an urgent need for investigating potential treatments. Traditional medicine offers many potential remedies that have been historically used and have the advantage of bypassing the cultural obstacles in the practice of medicine. We aimed to investigate the efficacy of Zufa syrup in the treatment of suspected patients with mild to moderate symptoms of COVID-19. This triple-blind randomized controlled trial recruited patients with evidence of COVID-19 on chest computed tomography without an indication of hospital admission from March 2020 until April 2020. Participants were assessed by a physician and completed a pre-specified form to assess the duration and severity of symptoms. Patients were randomized to receive Zufa syrup (a combination of herbal medicines: Nepetabracteata, Ziziphus jujube, Glycyrrhizaglabra, Ficuscarica, Cordia myxa, Papaver somniferum, Fennel, Adiantumcapillusveneris, Viola, Viper‘s-buglosses, Lavender, Iris, and sugar) or identical-looking placebo syrup at a dose of 7.5 mL (one tablespoon) every 4 hours for 10 days. After applying the eligibility criteria, 116 patients (49.1% male) were randomized to trial arms with a mean age of 44.3. During the follow-up, Cough, dyspnea, headache, myalgia, anorexia, anxiety, and insomnia improved gradually in both groups, and showed no difference between Zufa syrup and placebo. Oxygen saturation and pulse rate had stable trends throughout the follow-up and were similar between study arms. No patient required hospital admission or supplemental oxygen therapy during the study period. To conclude, in patients with mild to moderate symptoms of COVID-19, Zufa syrup did not show any difference in symptomatology over a 10 days’ period when compared with placebo. Due to potential effects of medicinal plants in the treatment of respiratory infections, further studies are warranted to clarify their role in COVID-19. The study was approved by the Ethics Committee of the Qom University of Medical Science (Ethics committee reference number IR.MUQ.REC.1398.165) on March 10, 2020 and was registered in Iranian Clinical Trial Center (approval ID: IRCT20200404046934N1) on April 13, 2020.
- Open Access
- 23 November 2021
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 32 (1)
Preliminary results of effect of barley (Hordeum vulgare L.) extract on liver, pancreas, kidneys and cardiac tissues in streptozotocin induced diabetic rats
Diabetes mellitus (DM) and its complications impose a significant burden on patients and the health care system. In the Traditional Persian Medicine (TPM), barley is recommended for treatment of DM. This study sought to assess the effect of barley seed aqueous extract on hepatic, pancreatic, renal and cardiac tissues in normal (non-diabetic) and Streptozotocin-induced diabetic rats. Twenty-one male Wistar rats were randomly divided into diabetic and non-diabetic groups. Diabetes was induced by single intraperitoneal injection of Streptozotocin. After one week, the diabetic and non-diabetic groups were randomly divided into control and barley seed extract subgroups namely N group (non-diabetic control rats), S group (seed extract treated non-diabetic rats), D group (diabetic control rats) and DS group (seed extract treated diabetic rats). After 6 weeks, all rats were sacrificed for histopathological analysis and specimens were stained routinely for histological studies. The abnormal histological signs significantly decreased in the DS group compared to D group. Also, protective effects of barley seed extract against histopathological changes were seen in S group compared to N group.These findings suggest that barley seed extract exerts a protective effect on different tissues in diabetes.
- 23 November 2021
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 32 (1)
Open AccessPreliminary results of effect of barley (Hordeum vulgare L.) extract on liver, pancreas, kidneys and cardiac tissues in streptozotocin induced diabetic rats
Diabetes mellitus (DM) and its complications impose a significant burden on patients and the health care system. In the Traditional Persian Medicine (TPM), barley is recommended for treatment of DM. This study sought to assess the effect of barley seed aqueous extract on hepatic, pancreatic, renal and cardiac tissues in normal (non-diabetic) and Streptozotocin-induced diabetic rats. Twenty-one male Wistar rats were randomly divided into diabetic and non-diabetic groups. Diabetes was induced by single intraperitoneal injection of Streptozotocin. After one week, the diabetic and non-diabetic groups were randomly divided into control and barley seed extract subgroups namely N group (non-diabetic control rats), S group (seed extract treated non-diabetic rats), D group (diabetic control rats) and DS group (seed extract treated diabetic rats). After 6 weeks, all rats were sacrificed for histopathological analysis and specimens were stained routinely for histological studies. The abnormal histological signs significantly decreased in the DS group compared to D group. Also, protective effects of barley seed extract against histopathological changes were seen in S group compared to N group.These findings suggest that barley seed extract exerts a protective effect on different tissues in diabetes.
- Open Access
- 1 May 2016
- Vol. 41, S37
Hijama (Wet Cupping or Dry Cupping) for Diabetes Treatment.
Diabetes is known as one of the most common diseases in the world and its treatment is one of the most important healthcare issues. Consequently, different treatment methods of complementary medicine and recent medicine have been used by scientific communities to control and predict the disease. This article considered the effects of dry cupping and wet cupping, based on traditional medicine and recent studies. At first, the benefits of dry cupping and wet cupping were taken from some original books of Iranian traditional medicine, such as Canon of Medicine, Kholasat-al-hekma, Tib-e-Akbari and Exir-e-Azam. Then, the information about scientific articles was obtained by studying some of the Iranian traditional medicine journals and searching through PubMed, SID and Google Scholar. In traditional medicine, Hijama is divided into two kinds, namely wet cupping (with sharat, with incision, and blood giving) and dry cupping (without sharat, without incision). Dry cupping causes organ blood absorption, organ warming, and loss of organ humidity. The texts of Iranian traditional medicine refer to the Ziabites disease that its symptoms are like diabetes. This disease is divided into two types including warm and cold ziabetes. The treatments that are recommended for both types are dry cupping for cold ziabetes and wet cupping for warm ziabetes. In addition, according to scientific studies, dry cupping and wet cupping have been recommended for diabetes treatment. Dry cupping and wet cupping can be introduced as the complementary treatment methods beside other treatment methods.
- 1 May 2016
- Vol. 41, S37
Open AccessHijama (Wet Cupping or Dry Cupping) for Diabetes Treatment.
Diabetes is known as one of the most common diseases in the world and its treatment is one of the most important healthcare issues. Consequently, different treatment methods of complementary medicine and recent medicine have been used by scientific communities to control and predict the disease. This article considered the effects of dry cupping and wet cupping, based on traditional medicine and recent studies. At first, the benefits of dry cupping and wet cupping were taken from some original books of Iranian traditional medicine, such as Canon of Medicine, Kholasat-al-hekma, Tib-e-Akbari and Exir-e-Azam. Then, the information about scientific articles was obtained by studying some of the Iranian traditional medicine journals and searching through PubMed, SID and Google Scholar. In traditional medicine, Hijama is divided into two kinds, namely wet cupping (with sharat, with incision, and blood giving) and dry cupping (without sharat, without incision). Dry cupping causes organ blood absorption, organ warming, and loss of organ humidity. The texts of Iranian traditional medicine refer to the Ziabites disease that its symptoms are like diabetes. This disease is divided into two types including warm and cold ziabetes. The treatments that are recommended for both types are dry cupping for cold ziabetes and wet cupping for warm ziabetes. In addition, according to scientific studies, dry cupping and wet cupping have been recommended for diabetes treatment. Dry cupping and wet cupping can be introduced as the complementary treatment methods beside other treatment methods.
- 1 April 2014
- Vol. 17 (4) , 299-301
Abul- Hasan al-Tabari: a review of his views and works.
Abul-Hasan al-Tabari was a 10th century Persian physician born in Tabaristan. He was a creative and innovative physician who avoided emulating treatments without investigating and examining them. Tabari was an encyclopedist and had a holistic view to medicine. Investigation of the views of this great Persian scholar indicated that his scientific and moral characteristics contain: paying adequate attention to philosophy and medical ethics, citing other scholars' works, attention to the necessity of clinical and hospital training, emphasizing indigenous therapy and scientific and responsible treatment with medical faults and discovery of Sarcoptes scabiei. Tabari has written valuable articles on different medical sciences; however, he is especially famous for authoring the al-Mu'alajat al-Buqratiya (Hippocratic Treatments) - an important medical encyclopedia. Several of Al-Tabari's succeeding scholars and physician have referred to the al-Mu'alajat al-Buqratiya in their medical articles. The aim of this study is further introduction of this great physician and assessment of his theories and key works.
- 1 April 2014
- Vol. 17 (4) , 299-301
Abul- Hasan al-Tabari: a review of his views and works.
Abul-Hasan al-Tabari was a 10th century Persian physician born in Tabaristan. He was a creative and innovative physician who avoided emulating treatments without investigating and examining them. Tabari was an encyclopedist and had a holistic view to medicine. Investigation of the views of this great Persian scholar indicated that his scientific and moral characteristics contain: paying adequate attention to philosophy and medical ethics, citing other scholars' works, attention to the necessity of clinical and hospital training, emphasizing indigenous therapy and scientific and responsible treatment with medical faults and discovery of Sarcoptes scabiei. Tabari has written valuable articles on different medical sciences; however, he is especially famous for authoring the al-Mu'alajat al-Buqratiya (Hippocratic Treatments) - an important medical encyclopedia. Several of Al-Tabari's succeeding scholars and physician have referred to the al-Mu'alajat al-Buqratiya in their medical articles. The aim of this study is further introduction of this great physician and assessment of his theories and key works.